Xeris Biopharma Holdings, Inc.
XERS • NASDAQ
Xeris Biopharma Holdings, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO John Shannon, with a market cap of $1.0B.
Market Cap$1.0B
Employees377.0
CEOJohn Shannon
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
XER
Xeris Biopharma Holdings, Inc. FAQ
Common questions about Xeris Biopharma Holdings, Inc.
Xeris Biopharma Holdings, Inc. is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $80.4M.
Xeris Biopharma Holdings, Inc. has approximately 377 employees.